Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2012
09/05/2012EP2493313A1 Kinase inhibitors
09/05/2012EP2493310A1 Benzimidazoles as fatty acid synthase inhibitors
09/05/2012EP2493308A1 Aryl aminopyridine pde10 inhibitors
09/05/2012EP2493305A1 2-aminoindole compounds and methods for the treatment of malaria
09/05/2012CN1980928B Phenanthroline derivative and light emitting element and light emitting device using the same
09/05/2012CN102656171A Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
09/05/2012CN102656161A 2,6-diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
09/05/2012CN102656159A Cgrp receptor antagonists
09/05/2012CN102656158A Novel heterocyclic acrylamides and their use as pharmaceuticals
09/05/2012CN102653538A Preparation method of SPD-502
09/05/2012CN102180874B Synthetic process method for azabicyclo medicinal intermediates
09/05/2012CN102093358B Brominated indolizinoquinoline dione derivative and application of brominated indolizinequinoline dione derivative in preparing antibiotic medicament
09/05/2012CN102093346B Preparation method of praziquantel
09/05/2012CN101641356B Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
09/05/2012CN101636385B Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists
09/05/2012CN101595109B 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
09/05/2012CN101448499B Use of cantffln-6-ketone and its analogues in the treatment of pathologies linked to mycobacteria
09/05/2012CN101367802B Beta-kabarin alkaloids in quassia wood, preparation method and application thereof
09/05/2012CN101304998B 7-substituted aza-indazoles, compositions containing same, production method and use thereof
09/04/2012US8258301 Urotensin II receptor antagonists
09/04/2012US8258172 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
09/04/2012US8258129 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
09/04/2012US8258122 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/04/2012US8257981 Lanthanide chelates and use thereof in bioanalysis
09/04/2012US8257838 Organic electroluminescent device and platinum compound
09/04/2012CA2656578C Tyrosine kinase inhibitors
08/2012
08/30/2012WO2012116288A1 2-amino-naphthyridine derivatives
08/30/2012WO2012116237A2 Heterocyclic compounds and uses thereof
08/30/2012WO2012116217A1 Compounds and compositions as trk inhibitors
08/30/2012WO2012115575A1 Derivatives for inducing osteogenic differentiation
08/30/2012WO2012115177A1 N-[(biaryloxy)alkylcarbonyl]sulfonamide derivative
08/30/2012WO2012115176A1 3-(biaryloxy)propionic acid derivative
08/30/2012WO2012114252A1 Novel indole and pyrrolopyridine amides
08/30/2012US20120220624 Pyrazolo [3,4-b] pyridin-4-one kinase inhibitors
08/30/2012US20120220623 The enantiomer of tenatoprazole and the use thereof in therapy
08/30/2012US20120220622 Heterocyclic derivatives
08/30/2012US20120220621 Anti-cancer compound and pharmaceutical composition containing the same
08/30/2012US20120220617 Fluorescent Perylene Derivatives for Direct Detection of Heparin
08/30/2012US20120220616 Novel spiropiperidine compounds
08/30/2012US20120220614 Substituted biaryl derivatives and methods of use thereof
08/30/2012US20120220610 Inhibitions of glutaminase c
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220583 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
08/30/2012US20120220572 Tricyclic inhibitors of kinases
08/30/2012US20120220571 Hiv integrase inhibitors
08/30/2012US20120220570 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220569 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220565 Pyridyl-amine fused azadecalin modulators
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120220457 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME
08/30/2012US20120219948 Application of quantum dots for nuclear staining
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120217492 Organic compound, organic electronic device using same, and terminal for same
08/30/2012US20120217449 Materials for electronic devices
08/30/2012DE102011012629A1 Metallkomplexe des Molybdäns und Wolframs und ihre Verwendung als Präkatalysatoren für die Olefinmetathese Metal complexes of molybdenum and tungsten and their use as pre-catalysts for olefin metathesis
08/30/2012DE102008047314B4 Radioaktiv-markierte Cyclopropan-Derivate DAT-affiner Tropane Radioactively labeled cyclopropane derivatives DAT affinity Tropanes
08/30/2012CA2828251A1 2-amino-naphthyridine derivatives
08/30/2012CA2828219A1 Pyrazolo [1,5-a] pyridines as trk inhibitors
08/29/2012EP2492270A2 Sod-imitating metal complexes
08/29/2012EP2492267A1 Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient
08/29/2012EP2491034A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491033A2 Azaindazoles to treat flaviviridae virus infection
08/29/2012EP2491032A1 Akt inhibitors
08/29/2012EP2491031A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491028A1 Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
08/29/2012EP2491009A1 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
08/29/2012EP2490693A1 PYRAZOLO [3,4-b]PYRIDIN-4-ONE KINASE INHIBITORS
08/29/2012EP2490692A1 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/29/2012CN102652128A 4 -oxo- iH -quinoline- 3 - carboxamides as modulators of ATP -binding cassette transporters
08/29/2012CN102649791A Method for extracting borrerine
08/29/2012CN102649790A (13aS, 14S)-14-amino phenanthroindolizidine alkaloid derivatives and preparation as well as plant virus resisting activity thereof
08/29/2012CN101906102B Beta-carboline alkaloid derivative, preparation method and application thereof
08/29/2012CN101870696B N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
08/29/2012CN101687887B Tricyclic nitrogen containing compounds as antibacterial agents
08/29/2012CN101379041B Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
08/29/2012CN101035786B Pyrrolopyridine derivatives and their use as CRTH2 antagonists
08/28/2012US8252932 Modified carbocyanine dyes and their conjugates
08/28/2012US8252930 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
08/28/2012US8252834 Dendrimer conjugates
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252814 Agents and crystals for improving excretory potency of urinary bladder
08/28/2012CA2711101C Fused heterocyclic derivatives and methods of use as c-met inhibitors
08/28/2012CA2703125C Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
08/28/2012CA2671744C Compounds and compositions as protein kinase inhibitors
08/23/2012WO2012112969A1 Aminoindane compounds and use thereof in treating pain
08/23/2012WO2012112963A1 Compounds and methods for treatment of hypertension
08/23/2012WO2012112962A1 Compounds and methods of treating diabetes
08/23/2012WO2012112961A1 Compounds and methods of treating hypertension
08/23/2012WO2012112742A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/23/2012WO2012112345A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/23/2012WO2012112232A1 METHODS AND COMPOSITIONS FOR TREATING β-THALASSEMIA AND SICKLE CELL DISEASE
08/23/2012WO2012111579A1 Light-emitting element
08/23/2012WO2012110970A1 Tetraazapyrene compounds and their use as n-type semiconductors
08/23/2012WO2012090177A3 Cannabinoid receptor modulators
08/23/2012WO2012089633A9 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
08/23/2012WO2011057706A8 Materials for electronic devices
08/23/2012US20120214993 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
08/23/2012US20120214990 Quinolinones and quinoxalinones as antibacterial composition
08/23/2012US20120214840 Indolizine inhibitors of 5-lipoxygenase
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 646